Page 196 - Read Online

Page 424 Saneto. J Transl Genet Genom 2020;4:384-428 I http://dx.doi.org/10.20517/jtgg.2020.40

homozygous mutation in FDX1. Brain 2018;141:2289-98.
237. Farhan SMK, Wang J, Robinson JF, Lahiry P, Sui VM, et al. Exome sequencing identifies NFS1 deficiency in a novel Fe-S cluster
disease, infantile mitochondrial complex II/III deficiency. Mol Genet Genomic Med 2014;2:73-80.
238. Lim SC, Friemel M, Marum JE, Tucker EJ, Bruno D, et al. Mutations in LYMR4, encoding iron-sulfur cluster biogenesis factory ISD11,
cause deficiency of multiple respiratory chain complexes. Hum Mol Genet 2013;22:4460-73.
239. Mochel F, Knight MA, Tong WH, Hernandex D, Ayyad K, et al. Splice mutation in the iron-sulfur cluster scaffold protein ISCU causes
myopathy with exercise intolerance. Am J Hum Genet 2008;82:652-60.
240. Koeppen AH. Friedreich’s ataxia: pathology, pathogenesis, and molecular genetics. J Neurol Sci 2011;303:1-12.
241. Torraco A, Stehling O, Stumpfig C, Rosser R, De Rasmo D, et al. ISCA1 mutation in a patient with infantile-onset leukodystrophy caused
defects in mitochondrial [4Fe-4S] proteins. Hum Mol Genet 2018;27:2739-54.
242. Kumar V, Kumar AA, Sanawar R, Jaleel A, Kumar TRS, et al. Membrane transporter ABCB7 which contributes to iron overload,
mitochondrial dysfunction, metabolic shift and worsens cardiac function. Sci Rep 2019;9:1370.
243. Kruer MC, Hiken A, Gregory A, Malandrini A, Clark P, et al. Novel histopathologic findings in molecularly-confirmed pantothenate
kinase-associated neurodegeneration. Brain 2011;134:947-58.
244. Hogarth P, Gregory A, Kruer MC, Wagoner W, Natowicz MR, et al. New NBIA subtype: genetic, clinical, pathologic, and radiographic
features of MPAN. Neurology 2013;80:268-75.
245. Gregory A, Lotia M, Joeng SY, Fox R, Zhen D, et al. Autosomal dominant mitochondrial membrane protein-associated neurodegeneration
(MPAN). Mol Genet Genomic Med 2019;7:e00736.
246. Dusi S, Valletta L, Haack TB, Tsuchiya Y, Venco P, et al. Exome sequence reveals mutations in CoA synthase as a cause of
neurodegeneration with brain iron accumulation. Am J Hum Genet 2014;94:11-22.
247. Almannai M, Alsamri, Alqasmi A, Faqeih E, Mutairi F, et al. Expanding the phenotype of SLC24A42-associated mitochondrial
encephalopmyopathy. Clin Genet 2018;93:1097-102.
248. Ma Z, Turk J. The molecular biology of the group VIA CA2+-independent phospholipase A2. Prog Nucleic Acid Res Mol Biol
2001;67:1-33.
249. Kinghorn KJ, Castillo-Quan JI, Bartolome F, Angelova PR, Li L, et al. Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation
and mitochondrial dysfunction. Brain 2015;138:1801-16.
250. Tello C, Darling A, Lupo V, Perez-Duenas B, Espinos C. On the complexity of clinical and molecular bases of neurodegeneration with
brain iron accumulation. Clin Genet 2018;93:731-40.
251. Mayr JA, Feichtinger RG, Tort F, Ribes A, Sperl W. Lipoic acid synthesis defects. J Inherit Metab Dis 2014;37:553-63.
252. Paul BT, Tesfay L, Winkler CR, Torti FM, Torti SV. Sideroflexin 4 affect Fe-S cluster biogenesis, iron metabolism, mitochondrial
respiration and heme biosynthesis enzymes. Sci Rep 2019;9:19634.
253. Hildick-Smith GJ, Cooney JD, Garone C, Kremer LS, Haack TB, et al. Macrocytic anemia and mitochondriopathy resulting for a defect
in sideroflexin 4. Am J Hum Genet 2013;93:906-14.
254. Giacomelli M, Pyakurel A, Clytsou C, Scorrano L. The cell biology of mitochondrial membrane dynamics. Nature Reviews/Mol Cell
Biol 2020;21:204-24.
255. Detmer SA, Chan DC. Functions and dysfunctions of mitochondrial dynamics. Nature Rev Mol Cell Biol 2007;8:870-9.
256. Waterham HR, Koster J, van Roermund CWT, Mooyer PAW, Wanders RJA, et al. A lethal defect of mitochondrial and peroxisomal
fission. N Engl J Med 2007;356:1736-41.
257. Schmid SJ, Wagner M, Goetz C, Makowski C, Freisinger P, et al. A de novo dominant negative mutation in DMN1L causes sudden onset
status epilepticus with subsequent epileptic encephalopathy. Neuropediatrics 2019;50:197-201.
258. Nasca A, Nardecchia F, Commone A, Semeraro M, Legati A, et al. Clinical and biochemical features in a patient with mitochondrial
fission factor gene alteration. Front Genet 2018;9:625.
259. Niemann A, Wagner KM, Ruegg M, Suter U. GDPA1 mutations differ in their effects on mitochondrial dynamics and apoptosis
depending on the mode of inheritance. Neurobiol Dis 2009;36:509520.
260. Chan DC. Dissecting mitochondrial fusion. Dev Cell 2006;11:592-4.
261. Renaldo F, Amati-Bonneau P, Slama A, Romana C, Forin V, et al. MFN2, a new gene responsible for mitochondrial DNA depletion. Brain
2012;135:e223.
262. Del Dotto V, Fogazza M, Carelli V, Rugolo M, Zanna C. Eight human OPA1 isoforms, long and short: what are they for? BBA
Bioenergetics 2018;1859:263-9.
263. Amati-Bonneau P, Valentino ML, Reynier P, Gallardo ME, Bornstein B, et al. OPA1 mutations induce mitochondrial DNA instability and
optic atrophy “plus” phenotypes. Brain 2008;131:338-51.
264. Kimura M, Okano Y. Human Misato regulates mitochondrial distribution and morphology. Exp Cell Res 2007;313:1393-404.
265. Gal A, Balicza P, Weaver D, Naghdl S, Joseph SK, et al. MSTO1 is a cytoplasmic pro-mitochondrial fusion protein, whose mutation
induces myopathy and ataxia in humans. EMBO Mol Med 2017;9:967-84.
266. Nasca A, Scotton C, Zaharieva I, Neri M, Selvatici R, et al. Recessive mutations in MSTO1 cause mitochondrial dynamics impairment,
leading to myopathy and ataxia. Hum Mutat 2017;38:970-7.
267. Girard M, Lariviere R, Parfitt DA, Deane EC, Gaudet R, et al. Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive
spastic ataxia of Charlevoix-Sagnuenay (ARSACS). Proc Natl Acad Sci 2012;109:1661-6.
268. Lee CA, Chin LS, Li L. Hypertonia-linked protein Trak1 functions with mitofusions to promote mitochondrial tethering and fusion.
Protein Cell 2018;9:693-716.